We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Cytokine "storm", cytokine "breeze", or both in COVID-19?
- Authors
Lippi, Giuseppe; Plebani, Mario
- Abstract
Sinha et al. conducted a prospective observational study, where clinical and laboratory correlates of COVID-19 patients with ARDS were compared to those of patients with COVID-19 unrelated ARDS [[7]]. Finally, the effectiveness of cytokine blockade by means of tocilizumab and other similar agents has been disputed for preventing the need of mechanical ventilation or mortality in COVID-19 patients with moderate illness [[14]]. Keywords: coronavirus; COVID-19; cytokines; inflammation EN coronavirus COVID-19 cytokines inflammation 637 639 3 03/13/21 20210401 NES 210401 The ongoing coronavirus disease 2019 (COVID-19) pandemic outbreak, which has seemingly emerged in Wuhan (China) at the end of 2019, has now spread all around the world, causing dramatic clinical consequences (in terms of morbidity, disability or mortality), a collapse of worldwide economies, raising also serious threats to human society [[1]].
- Subjects
COVID-19; TUMOR necrosis factors; CYTOKINES; FERRITIN; ABO blood group system; TUMOR necrosis factor receptors
- Publication
Clinical Chemistry & Laboratory Medicine, 2021, Vol 59, Issue 4, p637
- ISSN
1434-6621
- Publication type
Editorial
- DOI
10.1515/cclm-2020-1761